Production (Stage)
LAVA Therapeutics N.V.
LVTX
$1.32
$0.021.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.56M | 76.58M | 78.88M | 86.80M | 94.57M |
| Total Receivables | -- | -- | 1.03M | 1.15M | 907.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.56M | 1.07M | 1.63M | 2.22M | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.66M | 1.65M | -- | -- | -- |
| Total Current Assets | 69.78M | 79.30M | 81.54M | 90.17M | 96.67M |
|
|
|||||
| Total Current Assets | 69.78M | 79.30M | 81.54M | 90.17M | 96.67M |
| Net Property, Plant & Equipment | 1.28M | 1.44M | 1.71M | 1.97M | 2.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 95.00K | 91.00K | 114.00K | 144.00K | 256.00K |
| Total Assets | 71.16M | 80.83M | 83.36M | 92.28M | 99.08M |
|
|
|||||
| Total Accounts Payable | 1.52M | 2.72M | 2.82M | 4.16M | 3.44M |
| Total Accrued Expenses | 6.88M | 9.13M | 6.26M | 4.08M | 3.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 306.00K | 5.20M | 6.13M | 5.87M | 5.75M |
| Total Finance Division Other Current Liabilities | 1.66M | 949.00K | -- | -- | -- |
| Total Other Current Liabilities | 1.66M | 949.00K | -- | -- | -- |
| Total Current Liabilities | 10.37M | 18.01M | 15.20M | 14.11M | 13.03M |
|
|
|||||
| Total Current Liabilities | 10.37M | 18.01M | 15.20M | 14.11M | 13.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.00K | 80.00K | 164.00K | 295.00K | 387.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.00M | 35.00M | 35.00M | 35.00M | 35.00M |
| Total Liabilities | 45.37M | 53.09M | 50.36M | 49.41M | 48.41M |
|
|
|||||
| Common Stock & APIC | 215.91M | 215.37M | 198.17M | 198.16M | 198.15M |
| Retained Earnings | -178.45M | -174.97M | -168.93M | -156.72M | -148.48M |
| Treasury Stock & Other | -11.68M | -12.66M | 3.76M | 1.44M | 997.00K |
| Total Common Equity | 25.78M | 27.75M | 32.99M | 42.88M | 50.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.78M | 27.75M | 32.99M | 42.88M | 50.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.78M | 27.75M | 32.99M | 42.88M | 50.67M |
|
|
|||||